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Background: Intraoperative frozen section examination (IFSE) during breast cancer surgery can partly reflect the
status of surgical treatment since the surgical method used directly determines the purpose of IFSE use in disease
management. This study aims to investigate the application of, changing trends in, and factors influencing IFSE in
the management of female breast cancer in China.
Methods: We collected the sociodemographic and clinical data of 4,211 breast cancer patients between 1999 and
2008 and statistically analyzed these data using χ2 or Fisher’s exact tests.
Results: A total of 2,283 (54.22%) patients with breast cancer underwent IFSE. During the 10-year study period, IFSE
use was associated with an increase in the number of sentinel lymph node biopsies (SLNB) and breast-conserving
surgeries (BS) performed, with significant regional differences noted in this trend (P <0.05). Patients’ education,
occupation, age, tumor size estimated by preoperative palpation, and the use of imaging examinations affected the
purpose of IFSE use (P <0.05).
Conclusions: Our results show that the purpose of IFSE in the surgical treatment of breast cancer in China is
gradually approaching that in developed countries. We believe that policymakers must address the differences in
breast cancer treatment based on the socioeconomic status of patients. Lastly, the use of IFSE for determining
tumor characteristics should be avoided as far as possible, and patient education and breast cancer screening
programs tailored to the Chinese population should be established. Our findings may guide the formulation of
breast cancer control strategies in China and other low-income countries.
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Intraoperative frozen section examination (IFSE) was
first performed by William H. Welch in 1891. This
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unless otherwise stated.operation [1] and has become an indispensable part of
surgical treatment of breast cancer, since it can guide
operators in deciding the appropriate protocols during
surgery [2]. Before the 1980s, IFSE was mostly used to
determine the benignancy or malignancy of tumors in-
traoperatively [3]. Since 2000, with advances in tumor
treatment methods as well as preoperative diagnostic
methods, the use of IFSE has changed dramatically, es-
pecially in the case of breast cancer [4,5]. IFSE during
breast cancer surgery can reflect, to a certain extent, the
status of patients’ surgical treatment, since the surgicaltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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IFSE is used [6].
Although breast cancer is the most common cancer
among women in China [7], few studies have analyzed
the total population of breast cancer patients in the
country. Our previous studies demonstrated, for the first
time, the pathological characteristics of breast cancer in
Chinese women [8,9]. The current study is part of a
series of studies concerning the application and temporal
tendencies of and regional differences in IFSE use in the
diagnosis and treatment of female breast cancer in China
during the period 1999–2008. We also examined factors
affecting the purpose for which IFSE is used in breast
cancer management.Methods
Subjects
This series of studies was approved by the Institutional
Review Board of the Cancer Foundation of China. The
approval covered data collection from all the participat-
ing centers. Female patients with breast cancer who had
received treatment (surgery, medical oncology, radio-
therapy) were enrolled from seven first-class, grade III
hospitals or referral centers in north, northeast, central,
south, east, northwest, and southwest China [8]. Since
there was no risk associated with participating in the
study, patients’ informed consent was not obtained. The
identity of all patients was kept anonymous.Data collection
According to the pre-designed recruitment protocol, at
least 50 female patients with breast cancer were sampled
from each hospital or referral center per year. The sam-
pling method used could largely avoid selection bias.
Two data input clerks from each site independently
double-entered data from the patients’ record into a
computer database. Quality control was performed dur-
ing each step of data collection. Finally, all completed
double-entry databases were sent to the Cancer Hos-
pital/Institute, Chinese Academy of Medical Sciences,
for validation using the statistical software EpiData
(http://www.epidata.dk/). Details of the methods have
been described elsewhere [8].
Patient characteristics collected were general informa-
tion, risk factors, imaging examination results, treatment
mode, and clinicopathological characteristics of the tu-
mors. Histological subtyping of tumors was based
on the 1981 and 2003 WHO histological classification
criteria [10,11]. Breast cancer staging was performed
according to the American Joint Committee on Cancer
tumor-node-metastasis staging system of 1997 and after
[12,13].Grouping criteria
Subjects were assigned to two groups depending on the
reason for using IFSE. In Group A, IFSE had been used
for diagnosing the type of breast tumor, while in Group
B, it had been used to assess metastasis to a sentinel
lymph node (SLN) and/or to identify the resection mar-
gin during breast-conserving surgery (BS) but not to
identify the type of primary tumor.
The seven geographic regions mentioned were classi-
fied as high- or low-socioeconomic status (SES) areas,
according to previously described criteria [14]. Four so-
cioeconomic indicators were recorded: gross domestic
product per capita, percentage of health-service expend-
iture in the regional/provincial public affairs general
budget, ratio of urban to rural population, and percent-
age of illiteracy among females aged 15 and over. They
were used to establish the SES of each area with the se-
lected hospital or referral center.
According to the commonly used classification in
China, the ages of the patients at diagnosis of breast
cancer were divided into four groups: <35 years, 35–49
years, 50–64 years, and >64 years.Statistical analysis
All statistical analyses were performed using the statis-
tical software SPSS version 16.0 (SPSS Inc., Chicago, IL,
USA). The trend χ2 test was employed to examine the
temporal changes in IFSE application and its frequency
during the period 1999 to 2008. Factors affecting the use
of IFSE were analyzed using the χ2 test. The effect of
preoperative examination methods on the frequency of
IFSE use was evaluated using the χ2 test and Fisher’s
exact test. A P value <0.05 was considered statistically
significant.Results
Patient characteristics
A total of 4,211 eligible breast cancer patients were en-
rolled in this series of studies, which comprised 9.3% of
the total number of breast cancer cases encountered at
the hospitals or referral centers [8]. Included in the
4,211 patients were 2,283 patients (54.22%) who had
undergone IFSE. In terms of age, 139 patients (6.09%)
were aged under 35 years at diagnosis, 1,145 (50.15%)
were aged between 35 and 49 years, 793 (34.73%) be-
tween 50 and 64 years, and 206 (9.02%) above 64 years.
As mentioned, the seven geographic regions were
grouped into low- and high-SES areas according to the
area-based SES. High-SES areas were north, northeast,
east, and south China, with 1,227 subjects (53.75%); low-
SES areas were northwest, central, and southwest China,
with 1,056 subjects (46.25%).
Table 2 Frequency of intraoperative frozen section
examination (IFSE) use between 1999 and 2008
Year Group A (%) Group B (%) Total
1999 209 (99.52) 1 (0.48) 210
2000 165 (97.63) 4 (2.37) 169
2001 198 (99.50) 1 (0.50) 199
2002 176 (98.88) 2 (1.12) 178
2003 228 (95.80) 10 (4.20) 238
2004 227 (94.19) 14 (5.81) 241
2005 184 (91.09) 18 (8.91) 202
2006 240 (92.66) 19 (7.34) 259
2007 307 (91.92) 27 (8.08) 334
2008 226 (89.33) 27 (10.67) 253
Total 2,160 (94.61) 123 (5.39) 2,283
Group A: IFSE had been used for diagnosing the type of breast tumor.
Group B: IFSE had been used to assess metastasis to a SLN and/or to identify
the resection margin during BS but not to identify the type of primary tumor.
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The total number and percentage of the patients who
underwent IFSE during the 10-year study period did not
change significantly year-on-year, as shown in Table 1.
There was, however, a change in the reason for using
IFSE (Table 2 and Figure 1). The number and percent-
ages of IFSEs performed for identifying the type of pri-
mary tumor declined gradually, while the corresponding
figures for assessment of metastasis to SLNs or identifi-
cation of the resection margin increased gradually (P
<0.05). Overall, during the study period, 94.61% (2,160/
2,283) of IFSEs were used to identify the type of primary
tumor, 2.98% (68/2,283) for sentinel lymph node biopsy
(SLNB), and 9.46% (216/2,283) for BS. In most cases,
IFSE was used exclusively for identifying the type of pri-
mary tumor (2,014/2,283; 88.22%), whereas in 4.91% of
cases (112/2,283), it was performed to identify both the
type of primary tumor and the resection margin for BS;
fewer cases involved IFSE use exclusively for SLNB or
identification of the resection margin for BS. Thus, IFSE
for identifying the type of primary tumor (Group A)
accounted for 94.61% of cases (2160/2,283), while that
for other reasons accounted for 5.39% of cases (123/
2,283) (Group B; Table 2).Comparison of regional differences in the frequency of
IFSE
The frequency of IFSE use for various reasons differed
among the different SES regions as well. In low-SES
areas, the percentage of IFSE used for assessment of me-
tastasis to SLNs and/or identification of the resection
margin (Group B) was very low (1.52%; 16/1,056). In
contrast, in high-SES areas it was significantly higher
(8.72%; 107/1,227; P <0.05) (Figure 2).Table 1 Number and percentage of patients who
underwent intraoperative frozen section examination
(IFSE) between 1999 and 2008
Year IFSE (%) No IFSE or unknown (%) Total
1999 210 (52.11) 193 (47.89) 403
2000 169 (48.29) 181 (51.71) 350
2001 199 (52.79) 178 (47.21) 377
2002 178 (52.20) 163 (47.80) 341
2003 238 (61.03) 152 (38.97) 390
2004 241 (57.79) 176 (42.21) 417
2005 202 (49.75) 204 (50.25) 406
2006 259 (56.06) 203 (43.94) 462
2007 334 (58.80) 234 (41.20) 568
2008 253 (50.91) 244 (49.09) 497
Total 2,283 (54.22) 1,928 (45.78) 4,211Effect of sociodemographic characteristics on the
frequency of IFSE use
Table 3 shows the effects of patients’ sociodemographic
characteristics on indications for IFSE. Most patients
who underwent IFSE were educated up to junior and se-
nior high school (48.96%; 638/1,303), and the main oc-
cupation was manual work, accounting for 51.07%
(1,024/2,005) of the total patient population. A little
more than half the study population was in the 35 to
49 years age range (50.15%; 1,145/2,283). Statistical ana-
lyses showed that the level of education, occupation, and
age all affected the indications for IFSE, as follows: i)
Group A gradually reduced with advanced education
level, while Group B increased significantly (P = 0.001).
ii) The purpose of IFSE use also varied according to pa-
tients’ occupations. The highest percentage of Group AFigure 1 Temporal changes in the frequency of intraoperative
frozen section examination performed for (A) identifying the
type of primary tumor and (B) assessing metastasis to sentinel
lymph nodes and/or identification of the resection margin.
Figure 2 Comparison of the frequency of intraoperative frozen
section examination (IFSE) between low- and high-SES regions.
(A) IFSE use to identify the type of primary tumor. (B) IFSE use to
assess metastasis to sentinel lymph nodes and/or identification of
the resection margin.
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the highest percentage of Group B (8.37%) was found
among intellectual workers, and the between-group dif-
ference was significant (P <0.001). iii) Lastly, Group A
showed a gradually increasing tendency with age, while
Group B exhibited a gradually declining tendency with
age (P <0.001).
Effects of preoperative examinations on purpose of IFSE
use
The effects of preoperative examinations on the indica-
tions for IFSE are shown in Table 4. Both the tumor size,
determined by preoperative palpation, and the perform-
ance of molybdenum-target X-ray or ultrasonography
examinations prior to surgery affected the purpose ofTable 3 Effect of patients’ sociodemographic characteristics o
Sociodemographic characteristic Group A
Number Percenta
Education level Primary school and lower 372 98.4
Junior and senior high school 626 98.1
Junior college and higher 270 94.0
Total 1,268
Occupation Manual work 984 96.0
Intellectual work 569 91.6
Other** 344 95.5
Total 1,897





* Patients whose data were unavailable are not included in the table. ** Other: Tho
namely, housewives, merchants, soldiers, and unemployed individuals.IFSE use (P <0.05). IFSE was performed in a higher per-
centage for Group B purpose in patients who had tumor
sizes ≤20 mm or who had undergone molybdenum-
target X-ray or ultrasonography examinations (P <0.05);
on the contrary, the percentage of Group A was signifi-
cantly lower in these patients (P <0.05). The lymph node
status, determined by preoperative palpation, was not
significantly correlated with the purpose of IFSE use (P
>0.05).
Discussion
With continual advances in science and technology and
evolution of breast cancer treatment, IFSE plays an in-
creasingly important role in the surgical treatment of
this disease. Simultaneously, the principal purpose of
IFSE has shifted from identification of tumor type to
identification of SLN metastasis and assessment of the
resection margin during BS. In our previous nationwide
multicenter retrospective clinical epidemiological studies
of female breast cancer in China, we described the
pathological characteristics of this condition [8,9]. The
present study, which is part of a series of studies, investi-
gated the application of IFSE and factors that influence
its use in the management of female breast cancer. An
objective of this study was to guide the formulation of
breast cancer control strategies in China and other low-
income countries.
First, we analyzed the indications for IFSE and chan-
ging trends in its use. The results showed that IFSE was
still mainly used to identify the type of breast tumor.
However, its overall use for this purpose has declined
over the 10-year study period, while its use for assess-
ment of metastasis to SLNs and identification of then the frequency of IFSE use
Group B Total χ2
value
P
valuege (%) Number Percentage (%)
1 6 1.59 378
2 12 1.88 638 14.835 0.001
8 17 5.92 287
35 1,303*
9 40 3.91 1,024
3 52 8.37 621 15.902 <0.001
6 16 4.44 360
108 2,005*
1 25 17.99 139 59.602 <0.001
0 71 6.20 1,145
0 19 2.40 793
2 8 3.88 206
123 2,283
se with occupations that are difficult to classify as manual or intellectual work,
Table 4 Effects of preoperative examinations on the frequency of intraoperative frozen section examination use











Tumor size estimated by palpation ≤20 mm 752 93.07 56 6.93 808 5.842 0.016 –
>20 mm 1,408 95.46 67 4.54 1,475
Total 2,160 123 2,283




1,470 95.08 76 4.92 1,546 0.315 0.575 –
Metastasis
(N1–3)
566 94.49 33 5.51 599
Total 2,036 109 2,145*
Molybdenum-target X-ray Not used 1,368 96.75 46 3.25 1,414 12.333 <0.001 –
Used 655 93.44 46 6.56 701
Total 2,023 92 2,115*
Ultrasonography Not used 612 97.45 16 2.55 628 6.832 0.009 –
Used 1,421 94.92 76 5.08 1,497
Total 2,033 92 2,125*
MRI Not used 2,083 95.16 106 4.84 2,189 – – 0.088
Used 65 90.28 7 9.72 72
Total 2,148 113 2,261*
* Patients whose data were not available are not included in the table.
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dications for IFSE in China differ from those in devel-
oped countries, where SLNB and BS are the major
indications for surgical treatment of breast cancer
[15-27]. Correspondingly, the purpose of IFSE use has
changed. IFSE is increasingly being applied in SLNB and
BS and less so for identifying the type of primary tumor
[15]. Both the Edge report from the 28th Annual San
Antonio Breast Cancer Symposium [28] and the results
of the NSABP B-32 clinical trial [29] indicated that open
surgical resection combined with IFSE is no longer an
acceptable treatment for breast cancer in developed
countries. However, differences in economic levels may
necessitate differences in treatment modes for breast
cancer across countries [30-32]. The overall level of eco-
nomic development is significantly lower in China than
in developed countries, and this could affect disease-
control strategies. In the present area-stratified analysis,
we found that regional differences in economic develop-
ment affected the use of IFSE: regions with high-SES
tended to use IFSE for assessment of metastasis to SLNs
and identifying the resection margin during BS more fre-
quently than those with low-SES. We believe that in de-
veloping countries or regions, the use of preoperative
biopsy techniques should be increased in order to de-
crease the use of IFSE for intraoperative diagnosis of
breast tumor so that we can choose the more appropri-
ate treatment pattern before operation. Our results are
encouraging in that we found that the use of IFSE forSLNB and BS has significantly increased over the 10-
year study period, while its use for identifying the type
of primary tumor has decreased. This trend suggests
that surgical treatment of breast cancer in China is grad-
ually approaching that of developed countries. We be-
lieve that the influence of regional differences in
economic levels on the use of IFSE and breast cancer
control strategies deserves more attention as a means of
benefiting more patients.
We also evaluated the effects of patients’ sociodemo-
graphic characteristics on the use of IFSE for surgical
treatment of breast cancer. We found that the purpose
of IFSE use was closely associated with patients’ educa-
tion, occupation, and age. This association may be at-
tributed to the following factors: i) The time to diagnosis
is longer in the case of patients of lower educational
level, lower occupational income, and older age [33-35],
because of which they have advanced disease and the
opportunity to perform SLNB and BS is poor. ii) Sub-
jects with higher educational levels and income are more
willing to accept new concepts and technologies, such as
SLNB and BS [36,37]. iii) Subjects with lower incomes
cannot afford post-surgical radiotherapy, and most live
in poor areas where radiotherapy is seldom performed
[37]. iv) Younger patients are more likely to care about
the esthetics of surgery and hence may be more willing
to accept BS and SLNB [38,39], while older patients are
more prone to reject these two types of surgery [40]. On
the basis of these findings, we believe that better
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phasized in order to help them accept SLNB and BS.
Finally, we assessed the effects of preoperative exami-
nations on the purpose of IFSE use. Our previous study
showed that imaging examinations affected the clinico-
pathological characterization of breast cancer at diagno-
sis [9]. The current study found that the frequency of
imaging examinations also affected the rate of IFSE
use. Greater implementation of imaging examinations
led to greater use of IFSE for SLNB and BS. The follow-
ing reasons may explain this phenomenon: i) Breast
cancer can be detected at earlier stages in patients who
have undergone molybdenum-target X-ray and ultra-
sonographic examinations; therefore, their tumors may
be smaller and the possibility of SLN metastasis is lower
[41,42], and, consequently, these patients are more likely
to receive SLNB and BS. ii) Second, preoperative
molybdenum-target X-ray and ultrasonographic exami-
nations can better predict the safety of SLNB and BS
[43-45]. In the present study, we also found that tumor
size, as estimated by preoperative palpation, affected the
indications for IFSE, in that IFSE was used more fre-
quently for SLNB and BS in patients with tumors
≤20 mm. This finding may demonstrate that preopera-
tive estimation of tumor size is a key factor in determin-
ing whether BS will be performed [46,47], as BS is safest
when tumors are small [48]. Conversely, patients with
large tumors have a higher probability of having axillary
lymph node metastasis [49,50] and a greater risk of com-
plications from a SLNB [51,52].
Our study has a limitation, which must be acknowl-
edged: since subjects were enrolled from hospitals or re-
ferral centers in seven traditional geographic regions, a
selection bias may have been present. In China, most pa-
tients with breast cancer visit high-grade hospitals. All
hospitals or referral centers involved in the present study
are grade III and have the requisite physician resources
and equipment for performing IFSE. However, grade I
and II hospitals lack the resources to perform compre-
hensive breast cancer therapy, including IFSE. Nonethe-
less, since our study had a broad base and included
diverse populations, the selection method used is prob-
ably the most suitable to reflect the diverse nature of
present-day China.
Conclusions
In summary, in the present study, we analyzed the use
of IFSE in the diagnosis and treatment of breast cancer
in China during the 10-year period from 1999 to 2008.
From our observations, we concluded that IFSE is still
used mainly to identify the type of breast tumor. Ideally,
the use of preoperative biopsy techniques should be im-
proved so that IFSE use for tumor diagnosis during
breast cancer operations can be decreased. In line withthe introduction of newer concepts in breast cancer
treatment and treatment modes, the purpose of IFSE in
surgical treatment of breast cancer in China is gradually
approaching that of developed countries. Nevertheless,
regional differences in IFSE use require the attention of
policymakers. Finally, patients’ sociodemographic char-
acteristics and the availability and use of preoperative
imaging examinations significantly affect the use of IFSE
in breast cancer treatment. Therefore, better education
and breast cancer screening suitable for China’s needs
may help prevent breast cancer and aid the system in
serving those with this disease.
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